Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    11022927 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Resection+Highly Purified CTL Versus Resection Alone for HCC
Condition: Hepatocellular Carcinoma
Interventions: Procedure: resection;   Procedure: highly-purified CTL
2 Active, not recruiting Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced Hcc
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: Immuncell-LC
3 Completed
Has Results
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
Condition: Hepatocellular Carcinoma
Intervention: Biological: Immuncell-LC

Indicates status has not been verified in more than two years